Gara Jalqabaatti › Kansara Metastatikii › Distaarikii Koloombiyaa › Washington
Qorannoo klinikaalii Kansara Metastatikii Washington, DC keessatti
Qorannoo 43 Kansara Metastatikii f Washington fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Namoota walitti qabaa jiraSadarkaa 2
- Walter Reed National Military Medical Center, Bethesda · Miili 7 fagaatti
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
Namoota walitti qabaa jiraSadarkaa 2
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
A Study of ASP3082 in Adults With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Georgetown University Hospital, Washington D.C.
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Namoota walitti qabaa jiraSadarkaa 2/3
- Georgetown University, Washington D.C.
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
- The George Washington Medical facility Associates, Washington D.C.
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Namoota walitti qabaa jiraSadarkaa 2/3
- Georgetown University Medical Center - Department of Pharmacy, Oncology Pharmacy, Washington D.C.
- Georgetown University Medical Center, Washington D.C.
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Maryland Oncology Hematology, P.A., Silver Spring · Miili 7 fagaatti
- Maryland Oncology Hematology, P.A., Bethesda · Miili 7 fagaatti
- Maryland Oncology Hematology, P.A., Largo · Miili 11 fagaatti
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Namoota walitti qabaa jiraSadarkaa 1/2
- Georgetown University Medical Center, Washington D.C.
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Namoota walitti qabaa jiraSadarkaa 3
- MedStar Washington Hospital Center, Washington D.C.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Namoota walitti qabaa jiraSadarkaa 3
- MedStar Washington Hospital Center, Washington D.C.
- American Oncology Partners, PA, Bethesda · Miili 7 fagaatti
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Namoota walitti qabaa jiraSadarkaa 1/2
- MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026), Washington D.C.
Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers
Namoota walitti qabaa jiraSadarkaa 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · Miili 7 fagaatti
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Clinical Study Site, Washington D.C.
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
Namoota walitti qabaa jiraSadarkaa 2
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
Namoota walitti qabaa jiraSadarkaa 2
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · Miili 7 fagaatti
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Sibley Memorial Hospital, Washington D.C.
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Namoota walitti qabaa jiraSadarkaa 1/2
- Avenzo Therapeutics Recruiting Site, Washington D.C.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Namoota walitti qabaa jiraSadarkaa 3
- The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A., Bethesda · Miili 7 fagaatti
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · Miili 7 fagaatti
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Research Site, Washington D.C.
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers
Namoota walitti qabaa jiraSadarkaa 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · Miili 7 fagaatti
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
Namoota walitti qabaa jiraSadarkaa 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · Miili 7 fagaatti
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Namoota walitti qabaa jiraSadarkaa 1/2
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · Miili 7 fagaatti
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Washington D.C.
- Research Site, Silver Spring · Miili 7 fagaatti
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- George Washington University, Washington D.C.
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Namoota walitti qabaa jiraSadarkaa 3
- MedStar Washington Hospital Center, Washington D.C.
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Namoota walitti qabaa jiraSadarkaa 2
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Namoota walitti qabaa jiraSadarkaa 1/2
- Georgetown University Medical Center, Washington D.C.
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Namoota walitti qabaa jiraSadarkaa 3
- American Oncology Partners, P.A., Bethesda · Miili 7 fagaatti
Studying TAK-243 in Patients With Advanced Cancer
Namoota walitti qabaa jiraSadarkaa 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · Miili 7 fagaatti
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Namoota walitti qabaa jiraSadarkaa 2/3
- The Center for Cancer and Blood Disorders, Bethesda · Miili 7 fagaatti
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Namoota walitti qabaa jiraSadarkaa 3
- The George Washington University, Washington D.C.
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Namoota walitti qabaa jiraSadarkaa 2/3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Namoota walitti qabaa jiraSadarkaa 2/3
- Georgetown University Medical Center, Washington D.C.
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- National Cancer Institute, Bethesda · Miili 7 fagaatti
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Namoota walitti qabaa jiraSadarkaa 1
- Georgetown University Medical Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- American Oncology Partners of Maryland, Bethesda · Miili 7 fagaatti
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Namoota walitti qabaa jiraSadarkaa 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Silver Spring · Miili 7 fagaatti
- Massive Bio SYNERGY-AI site, Bethesda · Miili 7 fagaatti
Qorannoo Kansara Metastatikii magaalota biroo keessatti
- Houston, TXQorannoo 104
- New York City, NYQorannoo 93
- Nashville, TNQorannoo 70
- Boston, MAQorannoo 63
- Los Angeles, CAQorannoo 57
- St. Louis, MOQorannoo 54
- Arlington, VAQorannoo 53
- Philadelphia, PAQorannoo 46
- Chicago, ILQorannoo 45
- San Antonio, TXQorannoo 44
- Dallas, TXQorannoo 42
- Seattle, WAQorannoo 39
Qorannoo biroo Washington keessatti
- Saree (Gosoota Hunda)Qorannoo 58
- Kansara Qara'a Non-Small CellQorannoo 55
- Saree OljooQorannoo 46
- Dhibee QaraQorannoo 41
- Kansarii ProstateQorannoo 38
- ObesityQorannoo 33
- Kansarii ColorectalQorannoo 29
- Dhibee Onneessaa fi DhiigaQorannoo 28
- Dukkana BladderQorannoo 26
- Leukemia Myeloidii HamaaQorannoo 24
- Kansarii OvariiQorannoo 23
- LymphomaQorannoo 23
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.